Clinical features, treatment responses, and outcome of children with idiopathic thrombocytopenic purpura

Pediatric Hematology and Oncology

Volumn 26, Issue 7, 2009, Pages 526-532

  Demircioǧlu, Fatih ^a   Saygi, Murat ^a   Yilmaz, Şebnem ^a   Ören, Hale ^a   Irken, Gülersu ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

High dose methylprednisolone; Immune thrombocytopenic purpura; Intravenous immunoglobulin; Vaccination

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN; MEASLES MUMPS RUBELLA VACCINE; METHYLPREDNISOLONE; ORAL POLIOMYELITIS VACCINE;

ABDOMINAL BLEEDING; ADOLESCENT; ARTICLE; BLEEDING; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATURIA; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFANT; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; PRESCHOOL CHILD; PROGNOSIS; SCHOOL CHILD; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TREATMENT RESPONSE; VACCINATION;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT; MALE; METHYLPREDNISOLONE; PROGNOSIS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDIES;

EID: 70350062235     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010903044540     Document Type: Article

References (31)

1. Nugent DJ. Immune thrombocytopenic purpura of childhood. Hematol Am Soc Hematol Educ Program. 2006;97-103.
2. Rehman A. Acute immune thrombocytopenic purpura in children. Turk J Hematol. 2007;24:41-51.
3. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002;346:995-1008.
4. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3-40.
5. Bolton-Maggs PH, Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet. 1997;350:620-623.
6. Bolton-Maggs P. Severe bleeding in idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol. 2003;25(Suppl 1):47-51.
7. Buchanan GR. Bleeding signs in children with idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol. 2003;25(Suppl 1):S42-S46.
8. Lilleyman JS. Management of childhood idiopathic thrombocytopenic purpura. Br J Haematol. 1999;105:871-875.
9. Kühne T. Idiopathic thrombocytopenic purpura in childhood: controversies and solutions. Pediatr Blood Cancer. 2006;47(Suppl 5):650-652. (Pubitemid 44360017)
10. Buchanan GR, Adix L. Current challenges in the management of children with idiopathic thrombocytopenic purpura. Pediatr Blood Cancer. 2006;47(Suppl 5):681-684.
11. Imbach P. Development and research in idiopathic thrombocytopenic purpura: an inflammatory and autoimmune disorder. Pediatr Blood Cancer. 2006;47(Suppl 5):685-686.
12. Cooper N, Bussel J. The pathogenesis of immune thrombocytopaenic purpura. Br J Haematol. 2006;133:364-374.
13. Ozsoylu S, Irken G, Karabent A. High-dose intravenous methylprednisolone for acute childhood idiopathic thrombocytopenic purpura. Eur J Haematol. 1989;42:431-435. (Pubitemid 19150277)
14. Bolton-Maggs PH. Idiopathic thrombocytopenic purpura. Arch Dis Child. 2000;83:220-222.
15. Sutor AH, Harms A, Kaufmehl K. Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany. Semin Thromb Hemost. 2001;27:253-267.
16. Lilleyman JS. Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Arch Dis Child. 1994;71:251-253.
17. Buchanan GR. The nontreatment of idiopathic thrombocytopaenic purpura. Eur J Pediatr. 1987;146:107-112.
18. Chu YW, Korb J, Sakamoto KM. Idiopathic thrombocytopaenic purpura. Pediatr Rev. 2000;21:95-103.
19. Kühne T, Imbach P, Bolton-Maggs PH, Berchtold W, Blanchette V, Buchanan GR. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet. 2001;358:2122-2125.
20. Tarantino MD, Bolton-Maggs PH. Update on the management of immune thrombocytopenic purpura in children. Curr Opin Hematol. 2007;14:526-534.
21. Erduran E, Aslan Y, Gedik Y, Orhan F. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura. Turk J Pediatr. 2003;45:295-300.
22. Koçak U, Aral YZ, Kaya Z, Oztürk G, Gürsel T. Evaluation of clinical characteristics, diagnosis and management in childhood immune thrombocytopenic purpura: a single center's experience. Turk J Pediatr. 2007;49:250-255.
23. Ozsoylu S, Şaylý TR, Oztürk G. Oral megadose methylprednisolone versus intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol. 1993;10:317-321.
24. Duru F, Fýşgýn T, Yaralý N, Kara A. Clinical course of children with immune thrombocytopenic purpura treated with intravenous immunoglobulinGormegadosemethylprednisolone or observed without therapy. Pediatr Hematol Oncol. 2002;19:219-225.
25. Albayrak D, ÿIşlek I, Kalaycý AG, GürsesN. Acute immune thrombocytopenic purpura: a comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin. J Pediatr. 1994;125:1004-1007.
26. Yetgin S, Olcay L, Ozsoylu S, Hiçsönmez G, Gürgey A, Tuncer AM. Retrospective analysis of 78 children with chronic idiopathic thrombocytopenic purpura: follow-up from 1976 to 1996. Pediatr Hematol Oncol. 1997;14:399-412.
27. Watts RG. Idiopathic Thrombocytopenic Purpura: A 10-year natural history study at the Childrens Hospital of Alabama. Clin Pediatr (Phil). 2004;43:691-702.
28. Ahmed S, Siddiqui AK, Shahid RK, Kimpo M, Sison CP, Hoffman MA. Prognostic variables in newly diagnosed childhood immune thrombocytopenia. Am J Hematol. 2004;77:358-362.
29. Blanchette V. Childhood chronic immune thrombocytopenic purpura (ITP). Blood Rev. 2002;16:23-26. (Pubitemid 34293548)
30. Black C, Kaye JA, Jick H. MMR vaccine and idiopathic thrombocytopaenic purpura. Br J Clin Pharmacol. 2003;55:107-111.
31. Wang JD, Huang FL, Chen PY, Wang TM, Chi CS, Chang TK. Acute immune thrombocytopenic purpura in infants: associated factors, clinical features, treatment and long-term outcome. Eur J Haematol. 2006;77:334-337.